NCT06992245 Characterization of Placental Diffusion
| NCT ID | NCT06992245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hillel Yaffe Medical Center |
| Condition | Pregnancy in Diabetic |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-07-06 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-07-06 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
DW-MRI Allows a quantitative comparison of diffusion as an expression of tissue hypoxia. The investigators aim is to compare changes in placental diffusion in pregnant women with uncontrolled diabetes compared to healthy pregnant women using DW-MRI. The investigators hypothesize that placentas of diabetic mothers will show lower diffusion / perfusion compared to placentas of healthy women.
Eligibility Criteria
Inclusion Criteria: * Women with PGAM (Pre-gestational diabetes) diagnosed before 20 weeks of pregnancy * Women with GDMA (Gestational diabetes) diagnosed by OGTT after 20 weeks of pregnancy Exclusion Criteria: * pregnant women with placental hypoxia disease related in the past * pregnant women with placental hypoxia disease related in the present * non-singleton pregnancy * women in active labor or rupture of membrane * smoking women * suspicion of placenta accreta
Contact & Investigator
Rinat Gabbay-Benziv, Prof
PRINCIPAL INVESTIGATOR
Hillel Yaffe Medical Center
Frequently Asked Questions
Who can join the NCT06992245 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Pregnancy in Diabetic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06992245 currently recruiting?
Yes, NCT06992245 is actively recruiting participants. Contact the research team at rinatg@hymc.gov.il for enrollment information.
Where is the NCT06992245 trial being conducted?
This trial is being conducted at Hadera, Israel.
Who is sponsoring the NCT06992245 clinical trial?
NCT06992245 is sponsored by Hillel Yaffe Medical Center. The principal investigator is Rinat Gabbay-Benziv, Prof at Hillel Yaffe Medical Center. The trial plans to enroll 40 participants.